LUNG
Pulmonx Corporation Healthcare - Medical Devices Investor Relations →
Pulmonx Corporation (LUNG) closed at $1.36 as of 2026-03-20, trading 83.8% below its 200-week moving average of $8.37. This places LUNG in the extreme value zone. The stock is currently moving closer to the line, down from -80.1% last week. With a 14-week RSI of 29, LUNG is in oversold territory.
Over the past 14 weeks, up-weeks have carried more volume than down-weeks (1.51 buyers-vs-sellers ratio). When trading picks up, it's more often on days the price is rising — buyers are showing more interest than sellers.
Over the past 237 weeks of data, LUNG has crossed below its 200-week moving average 1 time. On average, these episodes lasted 237 weeks.
With a market cap of $57 million, LUNG is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -77.2%. The stock trades at 1.1x book value.
Share count has increased 11.0% over three years, indicating dilution.
Over the past 4.6 years, a hypothetical investment of $100 in LUNG would have grown to $4, compared to $161 for the S&P 500. LUNG has returned -51.6% annualized vs 11.0% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: LUNG vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After LUNG Crosses Below the Line?
Across 1 historical episodes, buying LUNG when it crossed below its 200-week moving average produced an average return of -56.0% after 12 months (median -56.0%), compared to -16.0% for the S&P 500 over the same periods. After 24 months, the average return was -73.0% vs +3.0% for the index.
Each line shows $100 invested at the moment LUNG crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
LUNG has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2021 | Ongoing | 237+ | 87.8% | Ongoing | -96.5% |
Frequently Asked Questions
Is LUNG below its 200-week moving average?
Yes. As of 2026-03-20, Pulmonx Corporation (LUNG) is trading 83.8% below its 200-week moving average of $8.37. The current price is $1.36.
What is LUNG's 200-week moving average price?
Pulmonx Corporation's 200-week moving average is $8.37 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when LUNG drops below its 200-week moving average?
LUNG has crossed below its 200-week moving average 1 time in our data. These episodes lasted 237 weeks on average.
Is LUNG a good value right now?
Here's what our data says about LUNG as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 29 (oversold). Free cash flow is currently negative. Return on equity is -77.2%. Price-to-book is 1.1x. This is not a buy or sell recommendation — always do your own research.
How does LUNG compare to the S&P 500?
Over the past 4.6 years, $100 invested in LUNG would have grown to $4, compared to $161 for the S&P 500. That's -51.6% annualized vs 11.0% for the index. LUNG has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20